Hormone Therapy Needs After Hysterectomy
Hysterectomy — surgical removal of the uterus — is one of the most common gynecological procedures in the United States, performed approximately 600,000 times annually. Its hormonal implications vary significantly based on whether the ovaries are also removed, and the resulting hormonal picture determines what therapy is indicated and how urgently it should be considered.
Hysterectomy Without Oophorectomy (Ovary-Preserving)
When the uterus is removed but the ovaries are preserved (most common in women under 50 with benign indications), the immediate hormonal impact is primarily loss of prostaglandin and progesterone from the uterus itself — which eliminates the menstrual cycle without necessarily producing hormonal deficiency. Ovarian estrogen and testosterone production continue, and menopause occurs at the expected natural timing (average age 51).
However, research consistently shows that hysterectomy — even with ovarian preservation — accelerates the timeline to ovarian decline. Women who have hysterectomies typically experience natural menopause 2–4 years earlier than age-matched women with intact uteri, possibly due to disruption of uterine-ovarian blood supply or hormonal crosstalk. This means earlier monitoring for perimenopausal symptoms is warranted after hysterectomy even with ovarian preservation.
An important clinical note: without a uterus, there is no endometrium to protect — meaning women who have had hysterectomy and choose to use estrogen therapy do NOT need progesterone or progestogen for endometrial protection. Estrogen-only HRT (without progestogen) can be used — a simplification that improves tolerability and reduces the cardiovascular concerns associated with synthetic progestin use.
Hysterectomy With Oophorectomy (Bilateral Salpingo-Oophorectomy)
When both ovaries are removed simultaneously (bilateral salpingo-oophorectomy, or BSO), surgical menopause is immediate and complete — regardless of age. Overnight, estrogen, progesterone, and testosterone production from the ovaries ceases. The hormonal withdrawal is more abrupt than natural menopause (which occurs gradually over years), producing rapid-onset and often severe menopausal symptoms: intense hot flashes, night sweats, vaginal atrophy, mood swings, and significant sleep disruption within days to weeks of surgery.
For women who undergo BSO under age 45, the health consequences of untreated surgical menopause extend well beyond symptom relief: significantly increased rates of cardiovascular disease, osteoporosis, cognitive decline, and all-cause mortality have been documented in women with premature surgical menopause who do not receive hormone therapy. The U.S. Preventive Services Task Force and the Menopause Society both recommend hormone therapy for women with premature or early surgical menopause, maintained at minimum until the age of natural menopause (51).
Testosterone After Hysterectomy
Testosterone — produced by the ovaries — is lost when oophorectomy is performed. Women who undergo BSO often experience striking reductions in libido, energy, and motivation alongside estrogen deficiency symptoms. Both estradiol and testosterone therapy are typically indicated in this population for full quality-of-life restoration. Women who retain their ovaries but experience persistent low libido after hysterectomy should also have free testosterone evaluated, as surgical disruption to ovarian blood supply can reduce ovarian androgen production even with preserved ovaries.
If you have had a hysterectomy and are experiencing symptoms of hormonal deficiency, call Multigen Wellness at (800) 259-0015 for a comprehensive evaluation tailored to your specific surgical history.